ReviewCancers2025
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond.
Matteo Molica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCancers2025
Matteo Molica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.